SynthesisEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
The enigma of culture-negative spondylodiscitis: comparable outcomes despite diagnostic uncertainty - a systematic review and meta-analysis.
Synthesis in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designSystematic review.
objectivesCulture-negative(CN) spondylodiscitis presents a diagnostic dilemma, as empirical antimicrobial therapy is often initiated without microbiological confirmation. This systematic review and meta-analysis compared the prevalence, risk factors, empirical antibiotic regimens, and outcomes of CN versus culture-positive(CP) spondylodiscitis.
methodsA comprehensive literature search identified studies reporting comparative outcomes between CN and CP cohorts. Data on prevalence, risk factors, antibiotic therapy, surgical rates, complications, and mortality were extracted and synthesised according to PRISMA guidelines.
resultsAcross 25 studies, the pooled CN prevalence was 43.2%(95%CI:33.8-52.6). CN status was consistently associated with prior antibiotic exposure, previous spinal/invasive procedures, bacteremia, diabetes, chronic kidney or liver disease, and intravenous drug use. CN cohorts had lower inflammatory markers(WBC, ESR, CRP) than CP. The mean duration of antibiotic therapy was similar between groups (CN:49-105 days; CP:56-112 days), with glycopeptides, β-lactams, fluoroquinolones, clindamycin, and tigecycline most frequently employed empirically. CN cohorts had significantly shorter hospital stays (SMD=-0.36;p = 0.002). Time to clinical recovery, cure rates, and recurrence(6-17%) showed no statistically significant difference compared to CP. Surgery was required in 20-40% of CN cases, with generally favourable outcomes and residual disability in 20-30%. Complication rates were not higher than CP. Mortality in CN cohorts was 1.8%, rising with comorbidity burden.
conclusionCN spondylodiscitis accounts for nearly half of all cases. Despite diagnostic uncertainty, no statistically significant difference in outcomes was detected compared to CP, with shorter hospitalisation and relatively low mortality, supporting the effectiveness of empiric antibiotic regimens guided by clinical and epidemiological context.
Indexed as
Identifiers
42262500What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.